Cormorant Global Healthcare Master Fund, Lp
Former 10% Owner at MoonLake Immunotherapeutics (MLTX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $46.9M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 1SEC | MLTXMoonLake Immunotherapeutics | Sell | 70,7488,423,403 held (−1%) | $9.38 | $664K | +15.4% |
| Oct 1SEC | MLTXMoonLake Immunotherapeutics | Sell | 232,4608,190,943 held (−3%) | $8.40 | $2.0M | +28.8% |
| Oct 1SEC | MLTXMoonLake Immunotherapeutics | Sell | 3,390,9434,800,000 held (−41%) | $7.58 | $25.7M | +42.7% |
| Oct 1SEC | MLTXMoonLake Immunotherapeutics | Sell | 2,800,0002,000,000 held (−58%) | $6.61 | $18.5M | +63.7% |
| Oct 1SEC | MLTXMoonLake Immunotherapeutics | Sell | 5,8271,994,173 held (−0%) | $6.96 | $41K | +55.5% |
- Sell
Former 10% Owner Cormorant Global Healthcare Master Fund, Lp sold $25.7M of MLTX at $7.58 — cuts the stake by 41%.
- Sell
Former 10% Owner Cormorant Global Healthcare Master Fund, Lp sold $18.5M of MLTX at $6.61 — cuts the stake by 58%.